T1-mapping by Cardiovascular Magnetic Resonance Imaging to Assess Non-Alcoholic Fatty Liver Disease

Dr. Andreas Kammerlander

Status: Unknown

Conditions: Valvular Disease; Heart Failure; NAFLD; Coronary Disease

Treatments: Diagnostic Test: T1 mapping on Cardiovascular Magnetic Resonance Studies

Study type: Observational

Funder types: Other

Identifiers

NCT04220450

NAFLD-CMR-2436

Details and patient eligibility

About

On clinically indicated Cardiovascular Magnetic Resonance studies, native T1-times and extracellular volume of the liver will be assessed and findings correlated with established risk calculators for non-alcoholic fatty liver disease.

Enrollment: 800 estimated patients

Sex: All

Ages: 18+ months old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Referred for Cardiovascular Magnetic Resonance Imaging

Exclusion criteria

• Non-compatible Devices